Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Recombinant BDNF fusion protein protects against Abeta-induced learning deficits

Feb. 6, 2008

BioLineRx reports positive results from phase IIa BL-1020 trial in schizophrenia

Feb. 5, 2008

Auris Medical completes patient enrollment in phase I/II trial with AM-101

Feb. 5, 2008

Solvay submits complete response to FDA approvable letter for Luvox CR

Feb. 5, 2008

Exercise-induced NMDA receptor activity prevents mature motor unit death in SMA

Feb. 5, 2008

Florida International University patent discloses novel free radical scavengers

Feb. 5, 2008

Escitalopram effective in treating multisomatoform disorder

Feb. 5, 2008

MediciNova's MN-166 reduces persistent black hole formation in MS

Feb. 4, 2008

FDA accepts BLA filing for Dysport in cervical dystonia

Feb. 4, 2008

M's Science initiates European phase II stroke recovery study

Feb. 4, 2008

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...